Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Elevated Prostate Specific Antigen (PSA)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00178113
What this trial is testing

A Pilot Study of Lycopene Supplementation in Prostatic Intraepithelial Neoplasia

Who this might be right for
Prostatic Intraepithelial Neoplasia
University of Pittsburgh 80
Testing effectiveness (Phase 2)Ended earlyNCT03442556
What this trial is testing

Docetaxel, Carboplatin, and Rucaparib Camsylate in Treating Patients With Metastatic Castration Resistant Prostate Cancer With Homologous Recombination DNA Repair Deficiency

Who this might be right for
ATM Gene MutationBRCA1 Gene MutationBRCA2 Gene Mutation+7 more
University of Washington 18
Testing effectiveness (Phase 2)Active Not RecruitingNCT04915508
What this trial is testing

Extremely Hypofractionated Intensity Modulated Stereotactic Body Radiotherapy for the Treatment of Prostate Cancer With Rising PSA After Radical Prostatectomy

Who this might be right for
Prostate AdenocarcinomaStage IIIB Prostate Cancer American Joint Committee on Cancer (AJCC) v8Stage IIIC Prostate Cancer AJCC v8+3 more
Jonsson Comprehensive Cancer Center 165
Not applicableStudy completedNCT02088164
What this trial is testing

Long-Term Outcome of Subjects With Elevated PSA in Healthy Taiwanese Men

Who this might be right for
Prostate Cancer
National Taiwan University Hospital 27,741
Large-scale testing (Phase 3)Study completedNCT04186845
What this trial is testing

Imaging Study to Investigate Safety and Diagnostic Performance of 18F rhPSMA 7.3 PET Ligand in Suspected Prostate Cancer Recurrence

Who this might be right for
Prostate Cancer
Blue Earth Diagnostics 391
Large-scale testing (Phase 3)Study completedNCT02673151
What this trial is testing

68Ga-PSMA PET/CT in Detecting Prostate Cancer Recurrence in Patients With Elevated PSA After Initial Treatment

Who this might be right for
Prostate AdenocarcinomaPSA FailureRecurrent Prostate Carcinoma
Andrei Iagaru 61
Not applicableWithdrawnNCT06804785
What this trial is testing

Hybrid Intelligence for Trustable Diagnosis and Patient Management of Prostate Cancer (HIT-PIRADS)

Who this might be right for
Prostate Cancer
Northwestern University
Testing effectiveness (Phase 2)Temporarily pausedNCT04519879
What this trial is testing

White Button Mushroom Sup for the Reduction of PSA in Pts With Biochemically Rec or Therapy Naive Fav Risk Prostate CA

Who this might be right for
Prostate AdenocarcinomaPSA FailurePSA Progression+7 more
City of Hope Medical Center 133
Large-scale testing (Phase 3)Study completedNCT02680041
What this trial is testing

18F Fluciclovine (FACBC) PET/CT in Patients With Rising PSA After Initial Prostate Cancer Treatment

Who this might be right for
Prostate Cancer
Blue Earth Diagnostics 221
Testing effectiveness (Phase 2)UnknownNCT03141671
What this trial is testing

Randomized Phase II Study of Salvage XRT + ADT +/- Abiraterone and Apalutamide for Rising PSA After RP (FORMULA-509)

Who this might be right for
Prostate Cancer
Dana-Farber Cancer Institute 345
Not applicableActive Not RecruitingNCT03891732
What this trial is testing

MRI Prostate for Chinese Men Being Screened for Prostate Cancer

Who this might be right for
Prostate CancerPSAMRI
Chinese University of Hong Kong 690
Post-approval studies (Phase 4)Study completedNCT00470834
What this trial is testing

Prostate Cancer Study In Men Who Have Failed First-Line Androgen Deprivation Therapy

Who this might be right for
Neoplasms, Prostate
GlaxoSmithKline 127
Testing effectiveness (Phase 2)Looking for participantsNCT06594926
What this trial is testing

Working Out M0 Bipolar Androgen Therapy

Who this might be right for
Prostate Cancer
Australian and New Zealand Urogenital and Prostate Cancer Trials Group 69
Testing effectiveness (Phase 2)Active Not RecruitingNCT03471650
What this trial is testing

Study of PSMA-targeted 18F-DCFPyL PET/CT for the Detection of Clinically Significant Prostate Cancer

Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 150
Large-scale testing (Phase 3)Ended earlyNCT00840294
What this trial is testing

Randomized Trial of Ciprofloxacin Versus Observation for Men With Elevated Prostate Specific Antigen (PSA)

Who this might be right for
Elevated Prostate Specific Antigen
University of Chicago 85
Testing effectiveness (Phase 2)Study completedNCT00658697
What this trial is testing

Docetaxel, Bevacizumab and Androgen Deprivation Therapy After Definitive Local Therapy for Prostate Cancer

Who this might be right for
Prostate Cancer
Dana-Farber Cancer Institute 42
Large-scale testing (Phase 3)Study completedNCT04838613
What this trial is testing

Study of Diagnostic Performance of [18F]CTT1057 in BCR

Who this might be right for
Prostatic NeoplasmsProstate CancerRecurrence
Novartis Pharmaceuticals 190
Testing effectiveness (Phase 2)Ended earlyNCT00050297
What this trial is testing

YM598 in Patients With Rising PSA After Initial Therapy for Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Astellas Pharma Inc
Not applicableStudy completedNCT04790968
What this trial is testing

Combined PSMA PET/MRI for Detection of Lymph Node Metastases in High-risk Prostate Cancer Patients

Who this might be right for
Prostatic NeoplasmsNeoplasm Metastasis
Norwegian University of Science and Technology 90
Large-scale testing (Phase 3)Ended earlyNCT00514917
What this trial is testing

Androgen Deprivation With Leuprolide, +/- Docetaxel for Clinically Asymptomatic Prostate Cancer Participants With a Rising Prostate Specific Antigen (PSA)

Who this might be right for
Prostatic Neoplasms
Sanofi 413
Next Page